v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 21, 2026
Apr. 04, 2025
Jan. 23, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]                
Number of share common stock sold     553,846          
Common stock, par value       $ 0.0001   $ 0.0001   $ 0.0001
Pre funded warrant permanent equity           Series A and Series B warrants as liability awards and the Pre-Funded Warrant as a permanent equity, using an allocation of 75% for the liability and 25% for the equity components.    
Common stock and/or pre-funded warrants           $ 2,300,000    
Incurred equity issuance costs     $ 800,000     30,000 $ 802,597  
Warrant liability     200,000          
Fair value adjustment of warrants     600,000          
Gross proceeds     9,000,000.0          
Notes payable     $ 2,900,000 $ 0   $ 0    
Series A warrants       3,477,775   3,477,775   3,477,775
Fair value of warrants           $ 53,142 $ 4,102,408  
Series A Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Derivative Liability       $ 1,300,000   $ 1,300,000    
Warrants exercised           0    
Fair value of Series A warrant liability           $ 200,000    
Unexercised Series A warrants           3,443,461    
Exercise price   $ 3.22            
Series A warrants   3,443,461            
Series B Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Derivative Liability       $ 5,400,000   $ 5,400,000    
Warrants exercised               10,173,402
Exercise price   $ 3.27            
Number of warrants     3,406,390          
Fair value of warrants     $ 5,400,000          
Series B Warrant [Member] | Minimum [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price     $ 3.22          
Common Stock [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercisable common shares     10,173,402          
Series A Common Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price     $ 20.00          
Series B Common Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price     20.00          
Series A and B Common Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price     16.250          
Prefunded Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price     $ 16.245          
Series A Preferred Stock [Member]                
Subsidiary, Sale of Stock [Line Items]                
Convertible preferred stock, shares outstanding       85,581   85,581   85,581
Conversion of shares       0 0 0 0  
Preferred stock, par value per share       $ 10   $ 10   $ 10
Series C Preferred Stock [Member]                
Subsidiary, Sale of Stock [Line Items]                
Convertible preferred stock, shares outstanding       1,688   1,688   1,688
Preferred stock, par value per share       $ 1,000   $ 1,000   $ 1,000
Preferred stock, convertible conversion price       $ 0.0092   $ 0.0092    
Securities Purchase Agreements [Member] | Private Placement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Common stock, par value $ 0.0001              
Securities Purchase Agreements [Member] | Investors [Member] | Private Placement [Member]                
Subsidiary, Sale of Stock [Line Items]                
Number of share common stock sold 17,500,000              
Common stock, par value $ 0.0001              
Offering price per share $ 0.04              
Gross proceeds $ 700,000